CY1108873T1 - Αναβραζοντα δισκια τα οποια διαλυονται εντος του ορου - Google Patents
Αναβραζοντα δισκια τα οποια διαλυονται εντος του ορουInfo
- Publication number
- CY1108873T1 CY1108873T1 CY20091100268T CY091100268T CY1108873T1 CY 1108873 T1 CY1108873 T1 CY 1108873T1 CY 20091100268 T CY20091100268 T CY 20091100268T CY 091100268 T CY091100268 T CY 091100268T CY 1108873 T1 CY1108873 T1 CY 1108873T1
- Authority
- CY
- Cyprus
- Prior art keywords
- agent
- seconds
- optionally
- mixture
- disintegrating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Physiology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Gynecology & Obstetrics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Non-Alcoholic Beverages (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
Η εφεύρεση αφορά αναβράζον, διαλυόμενο εντός του ορού δισκίο, το οποίον περιλαμβάνει τουλάχιστον μια δραστική ουσία, μείγμα εκδόχων που περιλαμβάνει τουλάχιστον ένα παράγοντα αποσαθρώσεως, διαλυτό παράγοντα αραιώσεως, ο οποίος διαλύει λιπαντικό παράγοντα και, ενδεχομένως, εσωτερικό αφυδραντικό παράγοντα, παράγοντα διογκώσεως, παράγοντα ο οποίος προσδίδει διαβρεκτική ικανότητα, γλυκαντικούς παράγοντες, αρωματικές και χρωστικές ύλες, και αναβράζοντα κοκκία με βάση μείγμα, το οποίο αποτελείται κυρίως από όξινο παράγοντα, κόλλα δυναμένη να εξωθείται εν θερμώ και αλκαλικό παράγοντα και, ενδεχομένως, αφυδραντικό παράγοντα και λιπαντικό παράγοντα, όπου τα αναφερθέντα κοκκία παρασκευάζονται δια εξωθήσεως εν θερμώ απουσία ύδατος και διαλυτών, και το αναφερθέν δισκίο αποσαθρούται εντός της στοματικής κοιλότητος σε επαφή με την σίελο σε ολιγότερο από 60 δευτερόλεπτα και κατά προτίμηση σε ολιγότερο από 40 δευτερόλεπτα.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0105389A FR2823668B1 (fr) | 2001-04-20 | 2001-04-20 | Comprimes effervescents orodispersibles |
EP02727667A EP1379222B1 (fr) | 2001-04-20 | 2002-04-17 | Comprimes effervescents orodispersibles |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1108873T1 true CY1108873T1 (el) | 2014-07-02 |
Family
ID=8862540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20091100268T CY1108873T1 (el) | 2001-04-20 | 2009-03-10 | Αναβραζοντα δισκια τα οποια διαλυονται εντος του ορου |
Country Status (15)
Country | Link |
---|---|
US (1) | US20040265380A1 (el) |
EP (1) | EP1379222B1 (el) |
JP (1) | JP2004525976A (el) |
CN (1) | CN1633282A (el) |
AT (1) | ATE416759T1 (el) |
CA (1) | CA2444506C (el) |
CY (1) | CY1108873T1 (el) |
DE (1) | DE60230249D1 (el) |
DK (1) | DK1379222T3 (el) |
ES (1) | ES2319266T3 (el) |
FR (1) | FR2823668B1 (el) |
HK (1) | HK1062404A1 (el) |
MX (1) | MXPA03009587A (el) |
PT (1) | PT1379222E (el) |
WO (1) | WO2002085336A1 (el) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
FR2834889B1 (fr) * | 2002-01-18 | 2004-04-02 | Roquette Freres | Forme pharmaceutique solide orodispersible |
US20030228370A1 (en) * | 2002-06-11 | 2003-12-11 | Michel Serpelloni | Orodispersible solid pharmaceutical form |
DE10232113A1 (de) | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
US8802139B2 (en) | 2003-06-26 | 2014-08-12 | Intellipharmaceutics Corp. | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
US8545881B2 (en) | 2004-04-19 | 2013-10-01 | Eurand Pharmaceuticals, Ltd. | Orally disintegrating tablets and methods of manufacture |
US8394409B2 (en) * | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
US20060039971A1 (en) * | 2004-08-19 | 2006-02-23 | Lee Robert E | Effervescent composition including alternative hormone replacement therapy agent |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
CA2584957C (en) | 2004-10-21 | 2015-08-25 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
JP2006182679A (ja) * | 2004-12-27 | 2006-07-13 | Daicho Kikaku:Kk | ストレス性胃炎予防・治療剤 |
DE102005009240A1 (de) | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
CA2612917A1 (en) * | 2005-06-23 | 2007-01-04 | Schering Corporation | Rapidly absorbing oral formulations of pde5 inhibitors |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
PE20070698A1 (es) * | 2005-11-14 | 2007-08-17 | Teijin Pharma Ltd | Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
CA2648280C (en) | 2006-04-03 | 2014-03-11 | Isa Odidi | Controlled release delivery device comprising an organosol coat |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
EP1902708A1 (de) * | 2006-09-25 | 2008-03-26 | Losan Pharma GmbH | Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung |
CN101938984A (zh) * | 2008-02-08 | 2011-01-05 | 高露洁-棕榄公司 | 清洁用组合物和方法 |
FR2938431B1 (fr) | 2008-11-14 | 2013-12-20 | Debregeas Et Associes Pharma | Nouvelle composition a base d'acide gamma-hydroxybutyrique |
PL387415A1 (pl) * | 2009-03-06 | 2010-09-13 | Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna | Kompozycja farmaceutyczna zawierająca celekoksyb oraz sposób jej wytwarzania |
JPWO2010119490A1 (ja) * | 2009-04-14 | 2012-10-18 | パナソニック株式会社 | 立体映像表示装置 |
US20110097401A1 (en) | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
FR2949062B1 (fr) | 2009-08-12 | 2011-09-02 | Debregeas Et Associes Pharma | Nouvelles formulations pharmaceutiques contre le mesusage des medicaments |
FR2949061B1 (fr) | 2009-08-12 | 2013-04-19 | Debregeas Et Associes Pharma | Microgranules flottants |
WO2011067667A2 (en) | 2009-12-02 | 2011-06-09 | Eurand Pharmaceuticals Limited | Fexofenadine microcapsules and compositions containing them |
WO2011101734A2 (en) | 2010-02-22 | 2011-08-25 | Lupin Limited | Taste-masked powder for suspension compositions of methylprednisolone |
US20150231092A1 (en) * | 2012-08-17 | 2015-08-20 | Sanovell IIac Sanayi Ve Ticaret Anonim Sirketi | Novel effervescent sachet formulations of dapoxetine and a pde5 inhibitor |
WO2014027981A2 (en) * | 2012-08-17 | 2014-02-20 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Effervescent tablet formulations of dapoxetine and a pde5 inhibitor |
FR3013221B1 (fr) * | 2013-11-19 | 2020-11-27 | Nabil Said | Composition pharmaceutique effervescente a base de sildenafil et son procede de fabrication |
CA3018828C (en) * | 2014-09-17 | 2021-05-11 | Steerlife India Private Limited | Effervescent composition and method of making it |
CN104224744A (zh) * | 2014-09-28 | 2014-12-24 | 严相顺 | 用于家蚕细菌病防治的环丙沙星泡腾片 |
WO2017098481A1 (en) | 2015-12-12 | 2017-06-15 | Steerlife India Private Limited | Effervescent compositions of metformin and processes for preparation thereof |
JP7166636B2 (ja) * | 2016-07-15 | 2022-11-08 | エイチツー ウォーター テクノロジーズ リミテッド | 水素豊富水を生成するための組成物及び他の製品 |
GR1009573B (el) * | 2018-03-28 | 2019-08-12 | Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας Και Αναπτυξης Α.Ε. | Αναβραζοντα φαρμακευτικα δισκια που περιλαμβανουν νατριοφωσφορικη υδροκορτιζονη |
CN117813089A (zh) * | 2021-07-09 | 2024-04-02 | 美国纳米食品药品公司 | 环氧合酶-2(cox-2)抑制剂组合物的制造方法 |
CN115843813B (zh) * | 2023-02-23 | 2023-05-12 | 山东金佑星水环境科技有限公司 | 一种复方氯溴泡腾速溶消毒片及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2097155T3 (es) * | 1989-10-02 | 1997-04-01 | Cima Labs Inc | Forma de dosificacion efervescente y metodo de administracion. |
US6709678B2 (en) * | 1996-08-15 | 2004-03-23 | Losan Pharma Gmbh | Easy to swallow oral medicament composition |
US6649186B1 (en) * | 1996-09-20 | 2003-11-18 | Ethypharm | Effervescent granules and methods for their preparation |
US6071539A (en) * | 1996-09-20 | 2000-06-06 | Ethypharm, Sa | Effervescent granules and methods for their preparation |
DE19822036A1 (de) * | 1998-05-15 | 1999-11-18 | Bayer Ag | Brausezubereitungen |
US20020160048A1 (en) * | 2001-02-15 | 2002-10-31 | Karoline Bechtold-Peters | Medical formulation containing a muscarinic agonist |
-
2001
- 2001-04-20 FR FR0105389A patent/FR2823668B1/fr not_active Expired - Lifetime
-
2002
- 2002-04-17 ES ES02727667T patent/ES2319266T3/es not_active Expired - Lifetime
- 2002-04-17 WO PCT/FR2002/001321 patent/WO2002085336A1/fr active Application Filing
- 2002-04-17 US US10/475,208 patent/US20040265380A1/en not_active Abandoned
- 2002-04-17 DE DE60230249T patent/DE60230249D1/de not_active Expired - Lifetime
- 2002-04-17 DK DK02727667T patent/DK1379222T3/da active
- 2002-04-17 CN CNA028104854A patent/CN1633282A/zh active Pending
- 2002-04-17 AT AT02727667T patent/ATE416759T1/de active
- 2002-04-17 CA CA2444506A patent/CA2444506C/fr not_active Expired - Lifetime
- 2002-04-17 MX MXPA03009587A patent/MXPA03009587A/es active IP Right Grant
- 2002-04-17 JP JP2002582910A patent/JP2004525976A/ja active Pending
- 2002-04-17 PT PT02727667T patent/PT1379222E/pt unknown
- 2002-04-17 EP EP02727667A patent/EP1379222B1/fr not_active Expired - Lifetime
-
2004
- 2004-07-08 HK HK04104960.4A patent/HK1062404A1/xx not_active IP Right Cessation
-
2009
- 2009-03-10 CY CY20091100268T patent/CY1108873T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2002085336A1 (fr) | 2002-10-31 |
MXPA03009587A (es) | 2004-12-06 |
DE60230249D1 (de) | 2009-01-22 |
HK1062404A1 (en) | 2004-11-05 |
JP2004525976A (ja) | 2004-08-26 |
EP1379222B1 (fr) | 2008-12-10 |
PT1379222E (pt) | 2009-03-16 |
FR2823668A1 (fr) | 2002-10-25 |
CA2444506A1 (fr) | 2002-10-31 |
EP1379222A1 (fr) | 2004-01-14 |
DK1379222T3 (da) | 2009-04-14 |
FR2823668B1 (fr) | 2004-02-27 |
CA2444506C (fr) | 2010-08-10 |
ES2319266T3 (es) | 2009-05-06 |
ATE416759T1 (de) | 2008-12-15 |
US20040265380A1 (en) | 2004-12-30 |
CN1633282A (zh) | 2005-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108873T1 (el) | Αναβραζοντα δισκια τα οποια διαλυονται εντος του ορου | |
WO2003053417A3 (fr) | Procede de fabrication d'un comprime incluant un analgesique de type morphinique et comprime obtenu | |
WO2002043719A3 (en) | Composition and method for treating snoring | |
TR200101224T2 (tr) | Hızlı bir biçimde dağılan gelişkin tablet. | |
ZA991408B (en) | Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent. | |
NO20043441L (no) | Orodispersibel farmasoytisk sammensetning omfattende agomelatin | |
EA200500129A1 (ru) | Прессованная жевательная резинка | |
DE602004029369D1 (de) | Halbfeste mukoadhäsive formulierungen | |
ATE335483T1 (de) | Orodispergierbare tabletten mit fexofenadin | |
PT893992E (pt) | Formas de dosagem oral de desintegracao rapida | |
PT910339E (pt) | Aerossol polar bucal | |
WO2004100817A3 (en) | Oral care tablet | |
MY136901A (en) | Water-soluble meloxicam granules | |
MXPA04003717A (es) | Tableta masticlabe que contiene lisina. | |
DK1619962T3 (da) | Præparat til oral administration der indeholder capsaicinoider | |
WO2004103283A3 (en) | Compositions of a cyclooxygenase-2 selective inhibitor and a central nervous system stimulant for the treatment of central nervous system damage | |
EP1967067A3 (en) | Use of neuronal sodium channel antagonists together with amitraz for the control of ectoparasites in homeothermic animals | |
ID29789A (id) | Suatu agen perasa tipe-hewani | |
WO2004071156A3 (en) | Use of edible acid in fast-dispersing pharmaceutical solid dosage forms | |
DE69813846D1 (de) | Geschmacksmaskierung schlecht schmeckender formulierungen | |
NO20030988L (no) | Anvendelse av en sammensetning omfattende et pollenekstrakt for behandlingav hormonrelaterte forstyrrelser | |
WO2002080962A8 (en) | Papaine containing pharmaceutical formulation resp. its use | |
AP2004003054A0 (en) | Combination of selective PDE4 inhibitor and an adrenergic beta-2 receptor agonist | |
RU2001100069A (ru) | Антгельминтное средство | |
UA37849A (uk) | Гірка настойка "білий туман" |